Get started
Author

N. Hansi

Process mapping the patient journey: an introduction
2010 · T. M. Trebble, N. Hansi, et al. · BMJ · 390
HBV-specific T cell responses in low replicating inactive carrier patients are independent of Hepatitis B surface antigen load
2018 · U.S. Gill, N. Hansi, et al. · Journal of Hepatology · 2
Combination of HBV serological markers can predict the burden and productivity of intrahepatic HBV reservoir and disease progression in HBeAg-negative chronic hepatitis B infection
2018 · R. Salpini, L. Colagrossi, et al. · Digestive and Liver Disease · 1
Editorial: the role of statins in the treatment of alcohol‐related cirrhosis
2017 · N. Hansi, M. J. Williams · Alimentary Pharmacology & Therapeutics · 1
Transcriptome profiles of NK and T cells associated with immune control in chronic hepatitis B patients treated with pegylated interferon alpha-nucleos(t)ide analogue sequential therapy
2017 · U.S. Gill, N.L. Bert, et al. · Journal of Hepatology · 1
An Immunological Biomarker to Predict Hepatic Flares upon Nuc Therapy Discontinuation in Chronic Hepatitis B
2016 · L. Rivino, N. Le Bert, et al. · Journal of Hepatology · 1
The integration of Hepatitis B virus into human genome is a common event in the setting of HBeAg negative chronic infection: implications for an altered cell homeostasis and metabolism
2019 · R. Salpini, L. Carioti, et al. · Digestive and Liver Disease
Gene Ontology Enrichment and Ingenuity Pathway Analysis Reveals Differentially Immune Regulated Networks in Treated Compared to Untreated Chronic Hepatitis B Patients.
2019 · U Gill, Nina Le Bert, et al. · Hepatology
Basal core promoter mutations as potential predictors of an enlarged intrahepatic HBV reservoir and enhanced cccDNA transcriptional activity in HBeAg negative chronic hepatitis B infection
2018 · L. Colagrossi, R. Salpini, et al. · Journal of Hepatology
Combination of HBV serological markers to predict the burden and productivity of intrahepatic HBV reservoir and disease progression in HBeAg negative Chronic Hepatitis B
2018 · V. Svicher, R. Salpini, et al. · Journal of Hepatology
HBV reservoir and enhanced cccDNA transcriptional activity in HBeAg negative chronic hepatitis B
2018 · L. Colagrossi, R. Salpini, et al. · Digestive and Liver Disease
Peripheral and intrahepatic virological phenotyping in HBeAg negative Chronic Hepatitis B to evaluate risk of disease progression and HCC in the “grey-zone” viral load cohort: Can grey-zone patients be candidate to treatment?
2017 · R. Salpini, L. Colagrossi, et al. · Digestive and Liver Disease
PD-1+ CD8+ T cells as immunological biomarkers for the safe discontinuation of anti-viral therapy in chronic hepatitis B
2017 · N. Le Bert, L. Rivino, et al. · Journal of Hepatology
Peripheral and intrahepatic virological phenotyping in eAg negative chronic hepatitis B to evaluate risk of disease progression and hepatocellular carcinoma in the “grey-zone” viral load cohort
2017 · V. Svicher, R. Salpini, et al. · Journal of Hepatology
PTH-107 Chronic Hepatitis B Management The UK: A National Survey of Current Practice Following Nice Guidance
2016 · N Hansi, P Troke, et al. · Gut
PTU-103 Characterisation of the immune profile in chronic hepatitis b patients following nucleos(t)ide discontinuation by cytof mass cytometry
2015 · L Rivino, M Van Den Berg, et al. · Gut
PTU-106 Identifying true immune-tolerant disease in children and young adults with chb using quantified hepatitis b surface antigen levels
2015 · N Hansi, US Gill, et al. · Gut
PTU-107 Defining the low-risk inactive carrier in chronic hepatitis b with qhbsag: do the same rules apply in children and young adults?
2015 · N Hansi, US Gill, et al. · Gut
PTU-117 Sequential NUC therapy following pegylated interferon provides a greater decline in HBSAG and potentially offers a treatment advantage over current therapies
2015 · US Gill, NK Hansi, et al. · Gut
P0474 : Characterisation of the immune profiles of chronic hepatitis B patients following NUC discontinuation by cyTOF mass cytometry
2015 · L. Rivino, M. Van Den Berg, et al. · Journal of Hepatology
High levels of Hepatitis B surface antigen (HBsAg) can exclude significant fibrosis and distinguishes true 'immune-tolerance' in children and young adults with Chronic Hepatitis B
2014 · N. Hansi, US Gill, et al. · Queen Mary Research Online (Queen Mary University of London)
PWE-122 How reliable is serological testing in the diagnosis of coeliac disease?
2012 · N Hansi, S Grainger · Gut
PDF
Works count: 22
Citation count: 396
H-index: 2
I10-index: 1
Year
Topic
Type